Some vital cancer‐related pathways were shown to be affected by these target genes of circMATR3, including FoxO, mTOR and MAPK signalling pathways (Figure 7D), suggesting that circMATR3 might be a potential therapeutic target for HSCC. The gene discussed is MTOR; the disease is cancer.